Clinical Trial

Otoferlin Gene-mediated Hearing Loss Natural History Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2022-10-05; most recent amendment 2026-03-03.
Trial Details
NCT Number NCT05572073
Lead Sponsor Akouos, Inc.
Collaborators: Eli Lilly and Company
Conditions Sensorineural Hearing Loss, Bilateral
Enrollment 150 participants
Start Date 2022-07-14
Primary Completion 2029-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-04